FRESH HOPE FOR DEMENTIA DRUG
Daily Record|July 04, 2024
Disease-modifying treatment approved in US
MARTIN BAGOT
FRESH HOPE FOR DEMENTIA DRUG

A NEW Alzheimer's drug has been approved in the US amid growing calls for the NHS to improve early diagnosis so Brits can benefit from the treatment.

UK regulators are still reviewing Donanemab, the world's first disease-modifying treatments for dementia, approved by the US Food and Drug Administration on Tuesday.

This story is from the July 04, 2024 edition of Daily Record.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

This story is from the July 04, 2024 edition of Daily Record.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.